In contrast, AMPK has also been shown to inhibit mTORC2 signaling by phosphorylating TSC2, which in turn downregulates the phosphorylation of mTOR in myeloma cells40 and non-small cell lung cancer cells41. Here, TSC2 is linked to non-small cell lung carcinoma.